At least with these drugs there is somewhat of an understandable reason for the confusion. First of all, only a relatively small percentage of bodybuilders have ever used higher-dose pharm-grade growth hormone for even a short period of time, let alone over the long-term, simply because it is too expensive for most to afford. This removes personal experience from the equation, automatically leaving 99%+ of all bodybuilders susceptible to the influence of fairy tales. Secondly, not all pharm-grade growth hormone is synthesized in the same fashion, which is the reason why different brands can provide different cosmetic effects. Anyone who has experience using multiple brands of GH will confirm that they do not all affect the body in the same way from a visual standpoint. Some cause significant water retention, while others cause much less by comparison.
Equipoise can produce androgenic side effects such as acne, accelerated hair loss in those predisposed to male pattern baldness and body hair growth. However, the overall androgenicity of this steroid is greatly reduced due to the structural nature that creates EQ in its double bond at the carbon one and two position. Such side effects of Equipoise are still possible, but they will be strongly linked to genetic predisposition, but most will find the threshold is fairly high.
When combating the possible androgenic side effects of Equipoise, it’s important to note they are brought on by the steroid being metabolized by the 5-alpha reductase enzyme. This metabolism will reduce Boldenone to an extremely potent androgen in dihydroboldenone, far more potent than dihydrotestosterone (DHT); however, the total dihydroboldenone activity has proven to be extremely low in human beings. You will further find the androgenic nature of Boldenone will not be significantly affected by 5-alpha reductase inhibitors like Finasteride that are often used to combat the reduction to DHT.
Due to the androgenic nature of Equipoise, women may potentially experience virilization symptoms. Virilization symptoms may include body hair growth, a deepening of the vocal chords and clitoral enlargement. However, the low androgenicity will make this steroid possible to use for some women without such symptoms. At the same time, the extremely slow acting nature of the compound can make it difficult to control regarding blood levels, and alternative steroids may be preferred. Without question, individual sensitivity will dictate a lot. If Equipoise is used and virilization symptoms begin to show, use should be discontinued immediately at their onset and they will fade away. If symptoms begin to show and are ignored, the symptoms may become irreversible.